These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 39412086)

  • 1. CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer.
    Liu S; Deng P; Yu Z; Hong JH; Gao J; Huang Y; Xiao R; Yin J; Zeng X; Sun Y; Wang P; Geng R; Chan JY; Guan P; Yu Q; Teh BT; Jiang Q; Xia X; Xiong Y; Chen J; Huo Y; Tan J
    Adv Sci (Weinh); 2024 Dec; 11(45):e2403782. PubMed ID: 39412086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer.
    Zacchi F; Abida W; Antonarakis ES; Bryce AH; Castro E; Cheng HH; Shandhu S; Mateo J
    Eur Urol Oncol; 2024 Dec; ():. PubMed ID: 39638687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LCP1 promotes ovarian cancer cell resistance to olaparib by activating the JAK2/STAT3 signalling pathway.
    Gai M; Zhao L; Li H; Jin G; Li W; Wang F; Liu M
    Cancer Biol Ther; 2024 Dec; 25(1):2432117. PubMed ID: 39588922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
    Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial.
    Hamilton EP; Falchook GS; Wang JS; Fu S; Oza AM; Imedio ER; Kumar S; Ottesen L; Mugundu GM; de Bruin EC; O'Connor MJ; Jones SF; Spigel DR; Li BT
    Target Oncol; 2024 Nov; 19(6):879-892. PubMed ID: 39487373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R; Hill S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
    Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N
    Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms restoring olaparib efficacy through ATR/CHK1 pathway inhibition in olaparib-resistant BRCA1/2
    Biegała Ł; Statkiewicz M; Gajek A; Szymczak-Pajor I; Rusetska N; Śliwińska A; Marczak A; Mikula M; Rogalska A
    Biochim Biophys Acta Mol Basis Dis; 2025 Feb; 1871(2):167574. PubMed ID: 39557132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy trap for guardian angels of DNA: Unraveling the anticancer potential of phthalazinone-thiosemicarbazone hybrids through dual PARP-1 and TOPO-I inhibition.
    Elkafoury EM; El-Hamamsy MH; El-Bastawissy EA; Afarinkia K; Aboukhatwa SM
    Bioorg Chem; 2024 Dec; 153():107924. PubMed ID: 39488147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an efficient NUPR1 inhibitor with anticancer activity.
    Liu X; Jimenez-Alesanco A; Li Z; Rizzuti B; Neira JL; Estaras M; Peng L; Chuluyan E; Garona J; Gottardo F; Velazquez-Campoy A; Xia Y; Abian O; Santofimia-Castaño P; Iovanna J
    Sci Rep; 2024 Nov; 14(1):29515. PubMed ID: 39604425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I.
    Stephenson ZA; Harvey RF; Pryde KR; Mistry S; Hardy RE; Serreli R; Chung I; Allen TE; Stoneley M; MacFarlane M; Fischer PM; Hirst J; Kellam B; Willis AE
    Elife; 2020 May; 9():. PubMed ID: 32432547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to improve smoking cessation rates in primary care.
    Lindson N; Pritchard G; Hong B; Fanshawe TR; Pipe A; Papadakis S
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011556. PubMed ID: 34693994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cepharanthine sensitizes gastric cancer cells to chemotherapy by targeting TRIB3-FOXO3-FOXM1 axis to inhibit autophagy.
    Lu YY; Fang YY; Wang SS; Guo J; Song JL; Zhu L; Lin ZK; Wang R; Zhang SY; Qiu WS; Qi WW
    Phytomedicine; 2024 Dec; 135():156161. PubMed ID: 39454374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted
    Young AJ; Pantel AR; Kiani M; Doot RK; Bagheri S; Pryma DA; Farwell MD; Li S; Lee H; Schubert EK; Secreto A; Zuckerman SP; Nayak A; Choi H; Carlin S; DeMichele A; Mankoff DA; Zhou R; Mach RH; McDonald ES
    J Nucl Med; 2024 Dec; 65(12):1862-1868. PubMed ID: 39477499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 & BRCA2 methylation as a prognostic and predictive biomarker in cancer: Implementation in liquid biopsy in the era of precision medicine.
    Panagopoulou M; Panou T; Gkountakos A; Tarapatzi G; Karaglani M; Tsamardinos I; Chatzaki E
    Clin Epigenetics; 2024 Dec; 16(1):178. PubMed ID: 39643918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effects of carbon ion radiation and PARP inhibitor on non-small cell lung carcinoma cells: Insights into DNA repair pathways and cell death mechanisms.
    Dey P; Das R; Chatterjee S; Paul R; Ghosh U
    DNA Repair (Amst); 2024 Dec; 144():103778. PubMed ID: 39486351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.